Bayesian Capital Management’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
Bayesian Capital Management's ORGO Position: Q2 2026 in Review
Bayesian Capital Management opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 14,500 shares worth $35.2K. The stake represents 0.02% of the portfolio and ranks #222 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in ORGO as recently as Q1 2025.
Bayesian Capital Management first reported a position in ORGO in Q1 2022 and has held it in 6 quarters since. The position peaked at $304K in Q1 2022. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.
- Bayesian Capital Management held 14,500 shares of Organogenesis Holdings worth $35.2K as of Q2 2026.
- Organogenesis Holdings was a new Bayesian Capital Management position in Q2 2026.
- Organogenesis Holdings made up 0.02% of Bayesian Capital Management's portfolio in Q2 2026, its #222 holding.
- Bayesian Capital Management first reported a position in Organogenesis Holdings in Q1 2022 and has held it in 6 quarters since.
- Bayesian Capital Management's Organogenesis Holdings position peaked at $304K in Q1 2022.
- 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.
Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.